indomethacin has been researched along with Cochlear Hearing Loss in 4 studies
Indomethacin: A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES.
indometacin : A member of the class of indole-3-acetic acids that is indole-3-acetic acid in which the indole ring is substituted at positions 1, 2 and 5 by p-chlorobenzoyl, methyl, and methoxy groups, respectively. A non-steroidal anti-inflammatory drug, it is used in the treatment of musculoskeletal and joint disorders including osteoarthritis, rheumatoid arthritis, gout, bursitis and tendinitis.
Excerpt | Relevance | Reference |
---|---|---|
"A 41-year-old man with pre-existing cardiac and renal dysfunction (for which his regular medications included furosemide) presumed secondary to a viral myocarditis developed acute sensorineural hearing loss 5 days after commencing treatment with indomethacin 25 mg tds for acute gout." | 3.76 | Irreversible sensorineural hearing loss: an unusual side effect of non-steroidal anti-inflammatory drugs. ( Ahmad, S; Bhanji, A; Karim, M; Pal, S, 2010) |
"Out of a population of 92 patients with Bartter syndrome, five suffered from mild to severe hypoacusia and were selected for mutational screening." | 1.33 | Type IV Bartter syndrome: report of two new cases. ( Bettinelli, A; Emma, F; Marseglia, GL; Palma, A; Taranta, A; Zaffanello, M, 2006) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Gupta, P | 1 |
Anne, RP | 1 |
Deshabhotla, SK | 1 |
Nerakh, G | 1 |
Ahmad, S | 1 |
Bhanji, A | 1 |
Pal, S | 1 |
Karim, M | 1 |
Shalev, H | 1 |
Ohali, M | 1 |
Kachko, L | 1 |
Landau, D | 1 |
Zaffanello, M | 1 |
Taranta, A | 1 |
Palma, A | 1 |
Bettinelli, A | 1 |
Marseglia, GL | 1 |
Emma, F | 1 |
4 other studies available for indomethacin and Cochlear Hearing Loss
Article | Year |
---|---|
Antenatal Indomethacin Use Altering the Initial Presentation of Type 4A Bartter Syndrome.
Topics: Bartter Syndrome; Female; Hearing Loss, Sensorineural; Humans; Indomethacin; Pregnancy; Prenatal Dia | 2021 |
Irreversible sensorineural hearing loss: an unusual side effect of non-steroidal anti-inflammatory drugs.
Topics: Acute Disease; Adult; Anti-Inflammatory Agents, Non-Steroidal; Gout; Hearing Loss, Sensorineural; Hu | 2010 |
The neonatal variant of Bartter syndrome and deafness: preservation of renal function.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arabs; Chromosomes, Human, Pair 1; Dietary Supplements; Fem | 2003 |
Type IV Bartter syndrome: report of two new cases.
Topics: Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Bartter Syndrome; | 2006 |